Population Pharmacokinetics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran, in Atrial Fibrillation Patients Receiving Long-Term Anticoagulation Therapy

By Bååthe Sofie  

Clinical Pharmacokinetics, Vol. 45, Iss. 8, 2006-01 ,pp. : 803-819

Adis International

Access to resources Recommend Favorite

What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?

By Okcun B   Yigit Z   Yildiz A   Uzunhasan I   Orta K   Baskurt M   Kaya A   Kucukoglu S  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 464-471

Field House Publishing

Access to resources Recommend Favorite

Cognitive Impairment as Determinant for Sub-Optimal Control of Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation

By van Deelen Bob A.J.  

Drugs & Aging, Vol. 22, Iss. 4, 2005-01 ,pp. : 353-360

Adis International

Access to resources Recommend Favorite

Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation

By Song Xue  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 245-253

Adis International

Access to resources Recommend Favorite

Anticoagulation prescription in atrial fibrillation

By Bertomeu-Gonzáález Vicente   Cordero Alberto   Mazóón Pilar   Moreno-Arribas Joséé   Fáácila Lorenzo   Nuññez Julio   Rodrííguez-Maññero Moiséés   Cosíín-Sales Juan   Gonzáález-Juanatey Jose Ramóón   Quiles Juan   Bertomeu-Martíínez Vicente  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1473-1479

Informa Healthcare

Access to resources Recommend Favorite